258 related articles for article (PubMed ID: 19597512)
1. Ureteral stent symptoms and associated infections: a biomaterials perspective.
Chew BH; Lange D
Nat Rev Urol; 2009 Aug; 6(8):440-8. PubMed ID: 19597512
[TBL] [Abstract][Full Text] [Related]
2. New developments in ureteral stent design, materials and coatings.
Chew BH; Duvdevani M; Denstedt JD
Expert Rev Med Devices; 2006 May; 3(3):395-403. PubMed ID: 16681460
[TBL] [Abstract][Full Text] [Related]
3. Current status of ureteral stent technologies: comfort and antimicrobial resistance.
Mendez-Probst CE; Fernandez A; Denstedt JD
Curr Urol Rep; 2010 Mar; 11(2):67-73. PubMed ID: 20425092
[TBL] [Abstract][Full Text] [Related]
4. Use of triclosan-eluting ureteral stents in patients with long-term stents.
Cadieux PA; Chew BH; Nott L; Seney S; Elwood CN; Wignall GR; Goneau LW; Denstedt JD
J Endourol; 2009 Jul; 23(7):1187-94. PubMed ID: 19538062
[TBL] [Abstract][Full Text] [Related]
5. Ureteral stents do not cause bacterial infections in children after ureteral reimplantation.
Uvin P; Van Baelen A; Verhaegen J; Bogaert G
Urology; 2011 Jul; 78(1):154-8. PubMed ID: 21256556
[TBL] [Abstract][Full Text] [Related]
6. Ureteral stent infections: a prospective study.
Altunal N; Willke A; Hamzaoğlu O
Braz J Infect Dis; 2017; 21(3):361-364. PubMed ID: 28189589
[No Abstract] [Full Text] [Related]
7. Technology insight: Novel ureteral stent materials and designs.
Chew BH; Denstedt JD
Nat Clin Pract Urol; 2004 Nov; 1(1):44-8. PubMed ID: 16474466
[TBL] [Abstract][Full Text] [Related]
8. Minimizing symptoms in patients with ureteric stents.
Duvdevani M; Chew BH; Denstedt JD
Curr Opin Urol; 2006 Mar; 16(2):77-82. PubMed ID: 16479208
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
[TBL] [Abstract][Full Text] [Related]
10. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial.
Mendez-Probst CE; Goneau LW; MacDonald KW; Nott L; Seney S; Elwood CN; Lange D; Chew BH; Denstedt JD; Cadieux PA
BJU Int; 2012 Sep; 110(5):749-54. PubMed ID: 22313688
[TBL] [Abstract][Full Text] [Related]
11. Symptoms Associated With Long-term Double-J Ureteral Stenting and Influence of Biofilms.
Betschart P; Zumstein V; Buhmann MT; Altenried S; Babst C; Müllhaupt G; Güsewell S; Schmid HP; Ren Q; Abt D
Urology; 2019 Dec; 134():72-78. PubMed ID: 31487513
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review.
Betschart P; Zumstein V; Piller A; Schmid HP; Abt D
Int J Urol; 2017 Apr; 24(4):250-259. PubMed ID: 28236323
[TBL] [Abstract][Full Text] [Related]
13. Prospects for the research and application of biodegradable ureteral stents: from bench to bedside.
Wang L; Yang G; Xie H; Chen F
J Biomater Sci Polym Ed; 2018 Oct; 29(14):1657-1666. PubMed ID: 30141744
[TBL] [Abstract][Full Text] [Related]
14. Diamond-like carbon coatings on ureteral stents--a new strategy for decreasing the formation of crystalline bacterial biofilms?
Laube N; Kleinen L; Bradenahl J; Meissner A
J Urol; 2007 May; 177(5):1923-7. PubMed ID: 17437849
[TBL] [Abstract][Full Text] [Related]
15. Influence of biofilms on morbidity associated with short-term indwelling ureteral stents: a prospective observational study.
Betschart P; Zumstein V; Buhmann MT; Albrich WC; Nolte O; Güsewell S; Schmid HP; Ren Q; Abt D
World J Urol; 2019 Aug; 37(8):1703-1711. PubMed ID: 30483946
[TBL] [Abstract][Full Text] [Related]
16. Ureteral stent-associated complications--where we are and where we are going.
Lange D; Bidnur S; Hoag N; Chew BH
Nat Rev Urol; 2015 Jan; 12(1):17-25. PubMed ID: 25534997
[TBL] [Abstract][Full Text] [Related]
17. Advances in ureteral stents.
Brotherhood H; Lange D; Chew BH
Transl Androl Urol; 2014 Sep; 3(3):314-9. PubMed ID: 26816785
[TBL] [Abstract][Full Text] [Related]
18. Surface modification of ureteral stents: development history, classification, function, and future developments.
Xia K; Shen X; Ang X; Hou B; Chen Y; Zhang K; Hao Z
Expert Rev Med Devices; 2023 May; 20(5):401-416. PubMed ID: 37038928
[TBL] [Abstract][Full Text] [Related]
19. Ureteral Stent Discomfort and Its Management.
Fischer KM; Louie M; Mucksavage P
Curr Urol Rep; 2018 Jun; 19(8):64. PubMed ID: 29892783
[TBL] [Abstract][Full Text] [Related]
20. Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: in vitro study.
Zelichenko G; Steinberg D; Lorber G; Friedman M; Zaks B; Lavy E; Hidas G; Landau EH; Gofrit ON; Pode D; Duvdevani M
J Endourol; 2013 Mar; 27(3):333-7. PubMed ID: 22970837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
